Related Experiment Video
Updated: Aug 15, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Bioinformatics, target discovery and the pharmaceutical/biotechnology industry
1Inpharmatica, 60 Charlotte Street, London, W1T 2NU, UK. r.fagan@inpharmatica.com
Abstract:
With the first draft of the human genome now available a directed genome-wide mining strategy is being implemented by many pharmaceutical and biotechnology companies in order to identify novel members of the most therapeutically relevant target families. At the same time there is an increasing amount of annotation relevant to the human genome sequence entering into the public domain. The ability to identify protein families on a genome-wide scale can only be done at speed by using high-throughput computational approaches. This review describes many of the latest algorithmic developments in this field and shows how they can be best put to use for target identification and prioritization.
Related Concept Videos
Protein-protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Drug Discovery: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacogenomics: Identification of New Drug Targets
Upstream Processing

